Honors

• Profiled in Chemical Biology & Drug Design 67(2), February 2006, “Who’s Who In Chemical Biology & Drug Design,” p. 187.
• Researcher of the Year Award (Full Professor), Florida Atlantic University, 2005-2006.
• Profiled in NanoBiotech News 3(36), September 21, 2005, “Florida Atlantic University, Moffitt get $1M to develop liposome-based drugs,” p. 7.
• Faculty of 1000 Biology, Chemical Biology Faculty, Protein Chemistry & Proteomics section, 2004-present.
• Distinguished Visiting Professor, Imperial College London, 2004.
• Profiled in Time Magazine 163(23), June 7, 2004, “The Secrets Of Their Success,” pg. 107-110.
• Invited Editor, Methods In Molecular Biology, 2003-present.
• Profiled in Boca Raton Magazine 23(3), May/June 2003, “8 Florida Scientists Who Are Saving Your Life: Breakthrough Medicine - Stopping The Spread Of Cancer,” pg. 98-100.
• Researcher of the Year Award (Full Professor), Florida Atlantic University, 2000-2001.
• Selected as one of "2000 Outstanding Scientists of the 21^st Century," 2000.
• Association of Biomolecular Resource Facilities (ABRF) Excellence Award in Peptide Synthesis Research, 1997.
• Profiled in Today's Life Sciences 9(1), January 1997, "Tumours and techniques," p. 36.
• Invited Editor, Methods In Enzymology, 1995-1998.
• Invited Guest Editor, Peptide Science: Comprehensive Reports & Reviews, 1994-1996.
• Invited Lecturer, Carlsberg Laboratory, Valby, Denmark, 1994.
• National Institutes of Health Research Career Development Award, 1994-1999.
• McKnight-Land Grant Professorship, University of Minnesota, 1993-1995.

Selected Professional Experience

1995-1997

Associate Professor, Department of Laboratory Medicine and Pathology and the Biomedical Engineering Center, University of Minnesota, Minneapolis, MN

1991-1995

Assistant Professor, Department of Laboratory Medicine and Pathology and the Biomedical Engineering Center, University of Minnesota, Minneapolis, MN

1988-1991

Postdoctoral Scholar with Professor Ken A. Dill, Department of Pharmaceutical Chemistry, University of California, San Francisco, CA

 

Selected Professional Activities

Editorial Boards

• Editorial Board, The Journal of Biological Chemistry, 2001-2006.
• Editorial Board, Current Protein And Peptide Science, 2000-present.
• Section Editorial Board, Expert Opinion On Therapeutic Patents, 1998-present.
• Editorial Board, The Journal Of Peptide Research, 1997-present.
• Editorial Advisory Board, Protein and Peptide Letters, Bentham Science Publishers B.V., 1994-present.
• Editor, Letters in Peptide Science, Escom Science Publishers B.V./Kluwer Science Publishers, 1993-present.

Grant Reviews

• Grant Proposal Reviewer, The Wellcome Trust, 2000.
• Member, Center for Scientific Review Special Emphasis Panel ZRG1-MEDB-1, National Institutes of Health, 2000.
• Member, Tissue Engineering Special Emphasis Study Section, National Institutes of Health, 2000-2001.
• Member, Bioengineering Research Partnership Special Emphasis Study Section, National Institutes of Health, 2000-2001.
• Grant Proposal Reviewer, National Science Foundation, 1999.
• Member, Center for Scientific Review Special Emphasis Panel ZRG1-MCHA-1, National Institutes of Health, 1999.
• Member, National Center for Research Resources, Research Centers in Minority Institutions, National Institutes of Health, Clark Atlanta University Site Visit, 1999.
• Member, Special Emphasis Panel Study Section ZRG1-CVB-02, Small Business Innovation Research (SBIR) and Technology Transfer (STTR) Grants, National Institutes of Health, 1999.
• Grant Proposal Reviewer, Research Corporation Cottrell College Science Awards, 1998.
• Grant Proposal Reviewer, National Science Foundation, 1998.
• Member, Hematology-1 Study Section ZRG4-HEM-01, Small Business Innovation Research (SBIR) and Technology Transfer (STTR) Grants, National Institutes of Health, 1998.
• Grant Proposal Reviewer, American Chemical Society Petroleum Research Fund, 1997.
• Grant Proposal Reviewer, Medical Research Council of Canada, 1996.
• Panel Member, Department of Defense CET-4 Breast Cancer Research Program, 1996.
• Grant Proposal Reviewer, North Carolina Biotechnology Center (NCBC), 1994.
• Grant Proposal Reviewer, National Science Foundation, 1994.
• Grant Proposal Reviewer, International Science Foundation, 1993.

Symposia Organization

• Session Co-Chair, Symposium on Synthetic Macromolecules with Higher Structural Order, 219^th American Chemical Society National Meeting, 2000.
• Session Chair, "Non-Globular Proteins: Folding and Function," 16th American Peptide Symposium, 1999.
• Co-Chair, 16th American Peptide Symposium: Peptides for the New Millennium, 1999.
• Session Chair, "Recent Advances in Synthetic Protein Construction and Utility," ABRF ‘99: Bioinformatics and Biomolecular Technologies - Linking Genomes, Proteomes and Biochemistry, 1999.
• Session Chair, Woessnerite Symposium on Proteases and Extracellular Matrix, 1998.
• Session Chair, Gordon Research Conference on Chemistry and Biology of Peptides, 1998.
• Co-Chair, Molecular Biophysics Symposium on Biomolecular Design, 1997.
• Session Chairman, 15th American Peptide Symposium, 1997.
• Member, Program Committee, 15th American Peptide Symposium, 1997.
• Session Chair, 24th Symposium of the European Peptide Society, 1996.
• Session Chair, "Peptide Structure And Design," Division of Medicinal Chemistry, 31st Annual American Chemical Society Western Regional Meeting & 4th Annual San Diego Biotech Exposition, 1995.
• Peptide Synthesis Workshop Leader, Ninth Symposium of the Protein Society, 1995.
• Peptide Synthesis Workshop Leader, Eighth Symposium of the Protein Society, 1994.

Externally Funded Research Support

• Mechanism & Inhibition of Collagenolytic Activity, National Institutes of Health R01-CA98799, 3/5/03-2/29/08.
• Peptide-Amphiphile Biomimetics for Targeted Therapies, National Institutes of Health R01-EB000289, 8/25/05-6/30/09.
• TIMP Engineering and Application to Arthritis, National Institutes of Health 1R01AR40994 (Keith Brew, P.I.; Gregg B. Fields, Co-P.I.), 4/1/03-3/31/08.
• MBRS Support of Continuous Research Excellence (SCORE) at Florida Atlantic University, National Institutes of Health 1S06GM073621 (Gregg B. Fields, Program Director), 6/1/05-5/31/09.
• State of Florida Center of Excellence in Biomedical and Marine Biotechnology (Larry F. Lemanski, P.I.; Russell G. Kerr, Project Director; Gregg B. Fields and 17 others, Co-P.I.), 9/1/03-2/28/07.
• ADAMTS/MMP Drug Development, National Institutes of Health 1X01MH078948, 8/1/06-7/31/07.
• Identification of Novel Compounds and New Targets for Cancer Therapy, FAU Center of Excellence for Biomedical and Marine Biotechnology, 9/1/03-8/31/05.
• Type IV Collagen in Melanoma Cell Invasion & Metastasis, Collagen Structural Modulation of Tumor Behaviors National Institutes of Health 8/1/95-4/30/03.
• Tissue Engineering Using Peptide-Amphiphile Biomimetics, National Institutes of Health, 7/15/98-6/30/03.
• Purchase of a 500 MHz Nuclear Magnetic Resonance Spectrometer, Kresge Foundation Science Initiative (Drs. Hank Steele, John Wiesenfeld, Gregg B. Fields, and Frank Marí, Co-P.I.), 9/17/98-9/16/00.
• Identification of AcrySof^TM Binding Domains Within Lens Capsule Components, Alcon Laboratories, 7/1/99-9/30/00.
• Identification of Novel Conopeptides, Cognetix Incorporated (Frank Marí, P.I.), 1/1/00-12/31/00.